UnitedHealth Says AI Will Save It $1 Billion in 2026 — Here Is Where That Money Actually Goes

Somewhere between a press release and a patient's denial letter, one billion dollars is in transit. UnitedHealth Group — the largest health insurer in the United States, with revenue of $113 billion in 2025 — told investors at its fourth-quarter earnings call in January 2026 that artificial intelligence would save it "nearly $1 billion" in operating costs this year. UnitedHealthcare CEO Timothy Noel called these reductions "AI-enabled." CFO John Rex confirmed the company would invest nearly $1.5 billion in AI in 2026 and a similar amount in 2027. The numbers are staggering. The implications are consequential. And the most important question — where does the money actually go? — is one that the company's investors know the answer to far better than the members paying their premiums every month.

The answer involves a new kind of war inside American healthcare, one being fought entirely by algorithms, with patients caught in the middle.

What UnitedHealth's AI Is Actually Doing

To understand where the billion dollars in savings is coming from, you need to understand what AI has replaced inside UnitedHealth's operations. The company's AI strategy is centered on Optum Real — an AI-first claims adjudication and reimbursement platform that was introduced only a few quarters ago and is already processing 500 million transactions in 2026, with expectations of reaching 2.5 billion by year-end. That volume makes it one of the highest-throughput transaction processing platforms in American healthcare. It processes claims decisions not in days but in seconds.

The specific changes are significant. Prior authorisation — the process by which a physician must get insurer approval before providing certain treatments — has historically been one of the most administratively burdensome elements of American healthcare. Nearly 95% of prior authorisation requests now arrive electronically, according to the Q1 2026 earnings call. About half process in real time. More than 90% are resolved within one business day. Authorisations submitted through UnitedHealth's Digital Auth Complete platform achieve a 96% first-submission approval rate, reducing the back-and-forth that previously consumed hours of clinical and administrative staff time. On the pharmacy side, an AI tool called PreCheck MyScript has cut prescription approval time from over eight hours to under 30 seconds and reduced denials tied to missing information by 68%. Digital transaction volumes across the provider network rose 75% year over year. About 75% of in-network providers now use portal or API tools to check eligibility and verify benefits without making a phone call.

These are genuine efficiency gains. Processing a prior authorisation in real time rather than taking three days is better for doctors and, in most cases, better for patients. Reducing manual contact costs by 76% — as Optum Real is reported to have done for certain claims categories — means fewer human processors needed, which is where much of the $1 billion in operating cost savings materialises. The money, in other words, is coming largely from labour reduction: fewer people needed to process claims, approve authorisations, handle phone calls, and manage the administrative layer that has historically made American healthcare so expensive to administer.

HCA Healthcare's $400 Million Bet — From the Other Side

UnitedHealth is not the only institution extracting enormous cost reductions from AI in 2026. HCA Healthcare, the largest publicly traded hospital chain in the United States, announced in January that it expects approximately $400 million in AI-driven cost savings this year. The mechanisms are different, and the context is revealing.

HCA has been using AI to automate revenue management — the process of ensuring that every service provided to a patient is coded and billed at the highest defensible level — and to reduce the administrative burden on clinicians by automating clinical paperwork. HCA's CFO Michael Marks had previously described the company's AI strategy as a response to what he called "growing denial and underpayment activities from the payers." That phrase is worth dwelling on. HCA is not primarily positioning its AI as a tool for improving patient care. It is positioning it as a weapon against health insurers who deny claims. When the largest hospital chain in America and the largest health insurer in America are both deploying AI against each other's financial interests, the question of who is optimising for patients becomes uncomfortably unclear.

The dynamic has generated colourful and troubling testimony. Centene CEO Sarah London described, at a September investor conference, a pattern where hospitals were using AI to classify virtually every emergency department patient presenting with a fever as a sepsis case — a much more expensive diagnosis. "There have been some of these pockets where folks coming into the emergency department with a fever, all of a sudden all have sepsis," she said. Sepsis triggers a cascade of medical interventions, each of which generates a higher billing code. Providence, a chain of 51 hospitals, describes its AI as helping to "accurately represent medical services rendered" — language that reads differently depending on whether you are the hospital submitting the claim or the insurer paying it.

The Blue Cross Blue Shield Finding: When AI Codes Its Way to $2 Billion

The most damaging evidence of what AI healthcare coding is actually producing came from the Blue Cross Blue Shield Association, whose research arm Blue Health Intelligence published an analysis of commercial hospital claims that nobody in the industry found easy to dismiss. The analysis found that roughly $663 million in inpatient spending and at least $1.67 billion in outpatient spending — a total approaching $2.3 billion — could be linked to more aggressive, AI-enabled coding practices at hospitals that had publicly disclosed AI adoption.

The specific example that the analysis used to illustrate the problem is striking in its precision. Researchers tracked a sharp rise in diagnoses of acute posthemorrhagic anemia — a condition caused by significant blood loss — at hospitals that had adopted AI. In many of the cases coded with this diagnosis, the patients never received blood transfusions, which are the standard treatment for the condition. The diagnosis was being applied algorithmically, in ways that triggered higher reimbursement codes, without a corresponding clinical indication that the diagnosis was accurate. That single coding pattern added $22 million to maternity admission costs in a single year across the hospitals studied.

The BCBS Association's vice president of clinical affairs, Razia Hashmi, framed the broader concern carefully but unmistakably: "We are seeing more AI tools used at different points in the care and billing process, and when those tools operate independently, they can unintentionally lead to friction." The word "unintentionally" is doing significant work in that sentence. Whether the overcoding is unintentional — the product of AI systems optimising for billing completeness without clinical supervision — or strategic — deliberately designed to maximise reimbursement — is a question that the data cannot answer definitively. The financial consequence is the same either way: more money flowing from insurers to hospitals, ultimately funded by premium payers.

The April 2026 testimony from Oregon insurer Regence added another dimension. "Given that providers are adopting AI tools at substantially higher rates than payers, transparency standards should apply equally to both," Regence lobbyist Mary Anne Cooper told legislators. The asymmetry in AI adoption — hospitals spending $1 billion on AI in 2025 compared to insurers spending approximately $50 million, according to Menlo survey data — means that hospitals currently hold the technological advantage in this billing arms race. UnitedHealth's $1.5 billion AI investment in 2026 is partly a response to that imbalance.

The Coverage Denial Problem No One Is Talking About Enough

Amid the focus on billing optimisation and claims processing efficiency, a quieter and more troubling application of AI has received less attention: the use of AI by insurers to make or assist in coverage denial decisions. The concern is not theoretical. UnitedHealth faced a class action lawsuit in 2024 — and significant scrutiny in the period since — alleging that its AI systems had been used to systematically deny coverage for rehabilitation and skilled nursing care for elderly patients, often overriding the clinical judgements of treating physicians. The lawsuit alleged that the AI's denial rate was far higher than human reviewers' historical rates, and that patients and their families were not informed that an algorithm had been involved in the decision.

The transparency dimension is fundamental. When a patient's claim is denied, they have a right to appeal. But appealing a denial effectively requires understanding why it was denied. If the denial was generated by an AI system applying actuarial models and coding patterns, and neither the patient nor their physician is told this, the information asymmetry is severe. The patient is being told no by an algorithm but believes they are being told no by a clinical reviewer. Their appeal strategy, their understanding of what additional documentation might change the outcome, and their ability to assert their rights are all compromised by that gap in transparency.

The American Medical Association has been among the most vocal critics of opaque AI use in coverage decisions, calling for mandatory disclosure to patients and physicians when AI has contributed to a coverage denial, and for requirements that AI-assisted denials be reviewed by a licensed clinician before they are transmitted. As of mid-2026, federal regulation in this area remains limited, though several states have passed or are considering legislation requiring insurer AI transparency.

What All of This Means for Your Health Insurance Costs

The honest answer to the question of whether AI in healthcare is good or bad for the average American's health insurance costs is: it depends entirely on who is winning the billing war, and whether the cost savings are passed on to policyholders or absorbed into profit margins.

McKinsey estimates that for every $10 billion in healthcare revenue, AI could save insurers approximately $970 million through claims management, prior authorisation, and clinical care guidance. If those savings were passed on to consumers as lower premiums, the potential benefit to the average American household would be substantial. The US spends more on healthcare than any other nation — approximately 18% of GDP — and administrative costs account for a disproportionately large share of that spending compared to peer countries. Reducing the administrative burden through AI, in a world where those savings are genuinely shared with consumers, is not a harmful development. It is one of the most promising cost-reduction mechanisms available.

The problem is the baseline assumption in that sentence. UnitedHealth Group reported earnings from operations of $9 billion in Q1 2026 alone. The company's full-year 2026 adjusted earnings per share guidance projects net earnings above $15.8 billion. The $1 billion in AI savings does not need to go anywhere specific for the company to meet its financial targets — it can simply expand margins. Whether it reduces premiums for UnitedHealthcare members depends on competitive dynamics, regulatory requirements, and the company's strategic choices — not on the mere fact that AI has made operations more efficient.

For patients, the most actionable understanding of what this situation means is twofold. First, AI is making claim processing faster, which is generally good when it means faster approvals and shorter waiting times for care. Second, AI is also being used — on both sides of the insurer-hospital divide — to maximise financial outcomes for the institutions deploying it. When your claim is denied, it may be because an algorithm determined it should be, and you have the right to request the specific clinical criteria used and to ask whether AI was involved in the decision. If AI was involved, you have the right to have a licensed human clinician review that decision before the denial is final. Exercising those rights may require asking for them explicitly.

Conclusion

The $1 billion in AI savings that UnitedHealth has projected for 2026 is real, driven by genuine efficiency gains in claims processing, prior authorisation, and administrative automation. HCA Healthcare's $400 million in parallel savings is equally real, driven by AI tools that ensure every billable service is coded and submitted at the highest supported level. The Blue Cross Blue Shield finding that AI-enabled coding has added $2.3 billion to claims spending is also real — and the three figures together describe a healthcare system in which AI is being deployed aggressively by every major institution for financial advantage, with patients caught in a crossfire they have had very little say in designing. The question of where the money goes — into lower premiums, expanded profits, or the escalating cost of an AI billing arms race — remains the most important unanswered question in American healthcare this year, and the answer is being shaped by decisions made in board rooms and data centres, not in examination rooms.

*This article is for informational purposes only and is not medical or financial advice. Data sourced from UnitedHealth Group Q1 2026 and Q4 2025 earnings releases (SEC Form 8-K), PYMNTS, Reuters, the Blue Cross Blue Shield Association, Menlo Park study of 700 healthcare executives, McKinsey, Morgan Stanley, and the Lund Report, as of June 2026.*